U.S. FDA Approves First Gene Therapies to Treat Patients With Sickle Cell Disease
The U.S. Food and Drug Administration (FDA) on Friday approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the...